NCT06172426View on ClinicalTrials.gov

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

CompletedOBSERVATIONAL
Enrollment

1,171

Participants

Timeline

Start Date

November 17, 2022

Primary Completion Date

December 7, 2022

Study Completion Date

December 7, 2022

Conditions
Psoriatic ArthritisPsoriasis
Trial Locations (1)

4002

Novartis, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY